Abstracts Archive - Page 775 of 1683 - ATC Abstracts

2018 American Transplant Congress
Peri-Operative Hemoglobin, Blood Transfusion and Delayed Graft Function in Kidney Transplant Recipients
S. MacIsaac, A. Ramankumar, C. Saw, V. Naessens, M. Cantarovich, D. Baran, S. Paraskevas, J. Tchervenkov, P. Chaudhury, S. Sandal.
MUHC, Montreal, Canada.
Background: Studies in the non-kidney transplant (KT) literature support an absolute hemoglobin concentration (Hb) threshold of 70 g/L for transfusion, unless otherwise indicated. Some reports…
2018 American Transplant Congress
Predictors of Kidney Transplant Recipient Readmissions
A. Crane, M. Eltemamy, D. Jacobsen, T. Coy, A. Sun, P. Babbar, M. Ponziano, E. Poggio, A. Wee, R. Fatica, V. Krishnamurthi.
Glickman Urology and Nephrology, Cleveland Clinic, Cleveland.
Introduction: Readmission rates for kidney transplant recipients is high and widely variable with a range of 18-47% nationwide. We aimed to characterize kidney transplant patients…
2018 American Transplant Congress
Pre-Existing Allograft Diabetic Nephropathy from Diabetic Donor is Reversible after Kidney Transplantation in Non-Diabetic Recipient
K. Hotta,¹ D. Iwami,¹ H. Harada,² Y. Fukasawa,² H. Okada,¹ H. Higuchi,¹ T. Hirose,² N. Fukuzawa,² N. Shinohara.¹
¹Hokkaido University Hospital, Sapporo, Japan; ²Sapporo City General Hospital, Sapporo, Japan.
【Introduction】The shortage of kidney donor has limited the treatment of patients with end-stage kidney disease. To use diabetic donor with normal renal function is would…
2018 American Transplant Congress
Use of Perfusion Machine after Long Cold Ischemia Time: 3 Years Results
A. Matos,¹ L. Requião-Moura,¹ E. Tonato,¹ M. Souza-Durão,^1,2 M. Borrelli,¹ M. Nogueira,¹ P. Rubio,¹ A. Pacheco-Silva.^1,2
¹Transplant, Hospital Israelita Albert Einstein, São Paulo, Brazil; ²Nephrology, Universidade Federal de São Paulo, São Paulo, Brazil.
The rate of delayed graft function (DGF) in Brazil is very high, reaching 80%. This is due to the long cold ischemia time (TIF) and…
2018 American Transplant Congress
Willingness to Consider Increased Risk Donors: A Single Center Experience
V. Richards,¹ C. Johnson,¹ J. Perkins,² A. Limaye,³ L. Sibulesky.²
¹Nephrology, University of Washington, Seattle, WA; ²Surgery, University of Washington, Seattle, WA; ³Allergy and Infectious Diseases, University of Washington, Seattle, WA.
Background: The number of Public Health Service increased risk organ donors (PHS IRD) is growing, largely due to the opioid epidemic.Methods: We conducted a retrospective…
2018 American Transplant Congress
Renal Allograft Transplantation among Middle Eastern Population with Alemtuzumab Induction
G. Mitro, O. Ekwenna, M. Rees, J. Ortiz.
University of Toledo College of Medicine, Toledo, OH.
Introduction: Renal allograft recipients of Middle Eastern (ME) heritage are often grouped together with Caucasians (CAU) for analysis. This abstract seeks to explore whether ME…
2018 American Transplant Congress
APOL1 Long-Term Kidney Transplantation Outcomes Network (APOLLO)
G. Guerra,¹ E. Poggio,² M. Ortigosa-Goggins,¹ M. Doshi,³ B. Freedman,⁴ D. Reboussin,⁴ P. Kimmel,⁵ APOLLO Investigators.
¹Miami Transplant Institute, Miami, FL; ²Cleveland Clinic, Cleveland, OH; ³University of Michigan, Ann Arbor, MI; ⁴Wake Forest School of Medicine, Winston-Salem, NC; ⁵NIDDK, Bethesda, MD.
Two renal-risk variants in the apolipoprotein L1 gene (APOL1) are powerfully associated with a spectrum of non-diabetic chronic kidney diseases in populations with recent African…
2018 American Transplant Congress
Evaluation of Accepting Kidneys of Varying Quality for Transplantation or Expedited Placement with Decision Trees
S. Mehrotra,¹ H. Gordon,¹ K. Bui,¹ J. Friedewald,² D. Ladner,² B. Kaplan,⁴ V. Kilambi.³
¹Industrial Engineering and Management Sciences, Northwestern University, Evanston, IL; ²Feinberg School of Medicine, Northwestern University, Chicago, IL; ³Operations Research, RAND Corporation, Boston, MA; ⁴Transplant Services, Baylor Scott and White, Houston, TX.
Underutilization of marginal-quality kidney-organs for transplantation has occupied the community and led to introducing the idea of expediting the placement of kidneys for populations at…
2018 American Transplant Congress
Allogeneic Mesenchymal Stem Cells as Induction Therapy Are Safe and Feasible in Renal Allografts: Pilot Results of a Multicenter Randomized Controlled Trial
Q. Sun,¹ F. Han,¹ M. Zhao,² R. Cao,³ D. Zhao,¹ Z. Huang,¹ L. Hong,¹ Y. Peng,¹ Q. Sun.¹
¹Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; ²Zhujiang Hospital, Southern Medical University, Guangzhou, China; ³Second Affiliated Hospital, Guangzhou Traditional Chinese Medicine University, Guangzhou, China.
Background: Delayed graft function (DGF) and acute rejection lead to adverse effects on graft outcomes. Optimal induction intervention should include both renal structure injury repair…
2018 American Transplant Congress
Ischemia-Free Liver Transplantation for Fatty Liver Grafts in Human
W. Ju, S. Huang, Z. Guo, G. Chen, X. He.
Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
BACKGROUND&AIMS: Fatty liver diseases have led to a continuous increase of available donor livers containing fat. Fatty liver grafts were identified as an independent risk…